After a downturn, biotech is rebounding with AI-driven innovation, strong M&A activity, and renewed investor interest. Advances in obesity and cancer treatments, along with AI’s role...
A well-managed European ETF could include biotechnology companies traded on one of the European exchanges as well as European-headquartered companies listed on U.S. exchanges. Stocks should...